Article

Sydney Morning HeraldSydney Morning Herald on 2018-05-23 04:42

US-listed Varian won't match Chinese offer for Sirtex

US cancer treatment developer Varian Medical has said it will not increase its offer to buy Australian biotechnology company Sirtex Medical.

Related news